New RNA and DNA-sequencing platform matches thousands of drugs to late-stage cancer patients
A comprehensive RNA and DNA sequencing platform benefits late-stage and drug-resistant multiple myeloma patients by determining which drugs would work best for them, according to results from a clinical trial published in ...
Aug 8, 2018
0
0